Kai Hibbard The Biggest Loser® Season Three Runner Up Introduced as Livea Celebrity Client

Kai Hibbard The Biggest Loser® Season Three Runner Up Introduced as Livea Celebrity Client

Outspoken contestant of NBC hit series is excited to lose 67 pounds with support of Livea®

Las Vegas, NV (PRWEB) January 9, 2010

Livea (www. Livea. com), the nation’s leading appetite control product for weight loss, announced Kai Hibbard as the product’s celebrity client and spokesperson. The spirited outspoken star of The Biggest Loser®, who was runner-up of Season Three, lost 67 pounds with Livea. This year, Kai resolves to help others live healthy by dedicating this New Years’ to helping people lose weight safely for the benefit of long-term success.

“After the series ended, real life took over and I started to gain weight. And after the birth of my son I just couldn’t get the weight off due to my continued cravings. I needed to gain control over my eating and Livea was the product that put me back in control,” said Kai. “My hope is that my story can provide the knowledge to everyone interested in properly losing weight and keeping it off. Through the use of Livea and a commitment to the Livea Lifestyle Program, I’m confident everyone can have the positive results I have had on Livea,” she added.

A self-proclaimed yo-yo dieter, Kai has battled weight issues all her life, but understood no one, including herself, could keep up the extreme dieting and exercise regime that allowed her to become the runner-up and third greatest weight loss female contestant of all-time on The Biggest Loser®. Determined to lose weight without using a product that includes caffeine, fat blockers and other stimulants, but rather wanting to only use an all natural product which would provide long-lasting results Kai selected Livea to help her lose weight and become healthy. Now Kai looks forward to sharing her success with others and embarking as an ambassador for the millions that want inspiration and a guaranteed successful weight loss journey.

"We're honored to have Kai promote Livea and we are very excited to have her lead the weight loss journey for the thousands of people wanting positive and long-lasting weight loss results,” said David McLane, CEO of WellWorld Science, the manufacturer of Livea. “Kai knows all the difficulties of losing weight and can help others take control over food. Her background of battling weight issues and finding success with Livea makes her the perfect person to lead the thousands of men and women who need help overcoming the challenges of becoming healthy.”

About Livea®
Livea (www. Livea. com) is a breakthrough dietary supplement that helps you lose weight in a safe and natural way by helping you control your appetite. Livea’s unique formula is based on a proprietary blend of all natural ingredients but does NOT contain stimulants, fat blockers, artificial sweeteners or any of the other synthesized ingredients typically found in today’s leading weight loss and appetite control products. Livea provides a Livea Lifestyle Program with easy and sensible guidelines to weight loss. The Livea Lifestyle program provides clients the tools for healthy, long-lasting natural weight loss.

Livea® is manufactured in the United States by WellWorld Science.
WellWorld Science develops and distributes a series of non-pharmaceutical/nutraceutical products specifically targeted to improve consumers’ general health, wellness, and well being. The company’s products, in general, target the ever-expanding global epidemic of the overweight condition and obesity. The company’s cornerstone product, Livea, is a patent-pending appetite control product that has mass appeal to the millions of adults in the United States considered overweight or obese by virtue of solving the issue of portion control and the feeling of satiety.

Livea was developed and is distributed by WellWorld Science. Livea® and WellWorld Science® are trademarks of WellWorld Science. ©2009 WellWorld Science. All rights reserved. FDA WARNING: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent and disease.

About Kai Hibbard
Kai Hibbard, 31, is a mother of one, The Biggest Loser® Season Three Runner-Up, a Certified AFAA Personal Trainer and celebrity spokesperson for Livea®. Kai, as a mother of one, had difficulty maintaining her groundbreaking weight loss after her series on The Biggest Loser® ended. After gaining the weight back, she needed help to take control over her food cravings. Skeptical of a new weight loss product, she tried Livea® and saw results within the first month. The product gave her the control over food she lacked and she has since lost 67 pounds and has been able to maintain her weight loss by leading a healthy lifestyle with the support of Livea®. Her success has inspired her to help others by partnering with Livea® to share her story and knowledge of overcoming the challenges of becoming healthy.

###

New, Full-Color STATIONSitter™ Guide Available from Sensaphone

New, Full-Color STATIONSitter™ Guide Available from Sensaphone

Sensaphone released a full-color application and information guide for its newest product line – the Sensaphone STATIONSitter™ remote monitoring and alarm notification system.

Aston, PA (PRWEB) January 25, 2006

Sensaphone, a pioneer in the design and development of remote monitoring systems for business and industry, today announced the availability of a new, full-color application and information guide for its newest product line – the Sensaphone STATIONSitter™ remote monitoring and alarm notification system.

The guide offers in-depth details, suggested applications, and technical specifications for the STATIONSitter, which is designed exclusively for the water and wastewater industries.

The Sensaphone STATIONSitter remotely monitors critical water and wastewater equipment and processes using the latest technology in alarm notification. The system monitors temperature, flow rate, tank levels, pressure, power, and other important conditions. When unfavorable or even dangerous conditions exist, the STATIONSitter automatically issues alarm notifications through custom voice messages, alphanumeric pages, and text messaging. It is also the first system of its kind to offer fully automatic configuration for easy installation.

An additional feature is the STATIONSitter’s built-in duplex pump control, which allows managers to switch pumps on and off from remote locations, creating equal wear and tear on the pumps. The STATIONSitter also offers a data logging capability where it collects and stores data and automatically generates and updates web pages.

To receive a free copy of the Sensaphone STATIONSitter guide, call 1-877-373-2700 or visit www. Sensaphone. com.

About Sensaphone:

Sensaphone stands at the forefront of remote monitor and control solution design, setting industry standards for advancements in technology. The Sensaphone family of products provides a comprehensive line of feature-rich, flexible technology for monitoring equipment, safeguarding property, and reporting critical data. Sensaphone serves a broad range of applications/industries, including telecommunications, network servers, computer rooms, oil and gas, water/wastewater, HVAC & refrigeration, science/health labs, agriculture, greenhouses, and vacation homes.

Sensaphone and STATIONSitter are registered trademarks of Phonetics, Inc.

# # #

Nobel Laureate J. Michael Bishop Joins the Scientific Advisory Board of the Rett Syndrome Research Trust

Nobel Laureate J. Michael Bishop Joins the Scientific Advisory Board of the Rett Syndrome Research Trust

The Rett Syndrome Research Trust announced today the appointment of Nobel Laureate J. Michael Bishop, Christopher Lipinski and Axel Unterbeck to its Scientific Advisory Board. The Trust welcomes the gracious participation of this elite group of scientists who join the existing members including preeminent Rett Syndrome researchers, Adrian Bird and Huda Zoghbi.

Trumbull, CT (PRWEB) June 17, 2009

The Rett Syndrome Research Trust announced today the appointment of Nobel Laureate J. Michael Bishop, Christopher Lipinski and Axel Unterbeck to its Scientific Advisory Board. The Trust welcomes the gracious participation of this elite group of scientists who join the existing members including preeminent Rett Syndrome researchers, Adrian Bird and Huda Zoghbi.

Dr. Bishop received the 1989 Nobel Prize in Physiology or Medicine with his colleague Harold Varmus, currently the President of Memorial Sloane-Kettering Cancer Center in New York City, for the revolutionary discovery of normal genes whose malfunction disposes cells to become cancerous.

Currently Chancellor of the University of California, San Francisco, Dr. Bishop is stepping down as of August 3rd after an eleven year tenure overseeing an unparalleled expansion of research facilities and accomplishments. He will continue to maintain his active laboratory and his position as Director of the G. W. Hooper Research Foundation at UCSF, which conducts multidisciplinary research on human disease.

"I know at first hand the personal and scientific challenges posed by Rett Syndrome and related disorders. I am eager to help the Rett Syndrome Research Trust in its quest for remedies to these tragic ailments," remarked Chancellor Bishop.

His many accolades include the Albert Lasker Basic Medical Research Award and the 2003 National Medal of Science, the nation's highest scientific honor. He is a member the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences, and has written and collaborated on several books in addition to nearly 400 scientific papers, publications, and reviews.

Joining Dr. Bishop is Christopher Lipinski, a world-renowned medicinal chemist best known for his groundbreaking "Rule of Five", an algorithm that has dramatically impacted the way that pharmaceutical industry approaches the development of orally active drugs. The 1997 publication which the "Rule of Five" first appears in is the most frequently cited medicinal chemistry paper in the last decade.

Currently, Dr. Lipinski is an independent medicinal chemistry consultant. In 2002 he retired from the highest scientific position in the worldwide Pfizer research organization (Senior Research Fellow) and now serves as a Drug-Like Properties consultant to a variety of profit and not for profit organizations.

"I am very pleased to join the SAB of the RSRT because I believe that a strong medicinal chemistry input is a very important contributor to bridging the formidable translational gap between breakthrough discoveries in academic biology and the actual discovery of a drug that benefits the patient," said Dr. Lipinski.

Dr. Lipinski serves on the scientific advisory board of Melior Discovery, a biotech company committed to identifying new therapeutic indications for pre-clinical and development-stage pharmaceuticals, as well as the KU Leuven University, Dundee University and MRC Technology UK drug discovery efforts. He is a member of the editorial board of the journal of Pharmaceutical Sciences and the highlights advisory board of Nature Reviews Drug Discovery. He is an adjunct faculty member in Biochemistry at the University of Massachusetts, Amherst, and has over 235 publications and invited presentations and 17 issued U. S. patents.

The Trust also welcomes Axel Unterbeck of Oxford Bioscience Partners, a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. He brings a wealth of experience spanning 23 years of R&D within the pharmaceutical and biotechnology industry. He held various positions at Bayer AG in Germany and the U. S., including Head of Central Nervous System/Dementia Research. Prior to joining Bayer AG, Dr Unterbeck was a member of the scientific team at the Institute for Genetics in Cologne which achieved the first full-length cloning of the human amyloid precursor protein (APP) gene implicated in Alzheimer's disease. In 2001 he co-founded with Nobel Laureate Eric Kandel Memory Pharmaceuticals where he served as President and Chief Scientific Officer. Memory Pharmaceuticals was recently purchased by Roche.

"I am delighted to be working with Monica Coenraads and RSRT's translational effort. At this critical point in Rett Syndrome research, the Trust is uniquely positioned to promote research towards multiple pathways for drug discovery and development and to identify new avenues for therapeutic intervention in this complex field. RSRT's high standards and ability to engage extraordinary scientists and thinkers, combined with Monica's ten-year track record of progress in this field, should inspire the confidence and hope of Rett families everywhere," said Dr. Unterbeck.

"Chancellor Bishop is a thoughtful man who cares deeply about science and its translation. His decision and that of Drs. Lipinski and Unterbeck, to join our board, is an incredible vote of confidence with regards to RSRT's efforts. The intellectual capital behind the Trust coupled with our ability to drive meaningful collaborations between academia and industry will be key to the successful development of interventions. We are honored and grateful to Chancellor Bishop, Dr. Lipinski, Dr. Unterbeck and to all of our scientific advisors for their commitment to our cause," remarked Monica Coenraads, executive director of RSRT and mother of a child afflicted with Rett Syndrome.

About the Rett Syndrome Research Trust
The Rett Syndrome Research Trust is a nonprofit research organization formed in the wake of the dramatic pre-clinical reversal of Rett Syndrome symptoms. The Trust is intensively and exclusively focused on the development of treatments and cures for Rett Syndrome and related MECP2 disorders. Our short-term goal is to deliver clinical trials of a novel treatment strategy within five years. The strength of the Trust is based on the guidance of scientific advisors who are largely responsible for the major advances in Rett research over the past decade. To learn more about the Trust please visit www. ReverseRett. org

About Rett Syndrome
Rett Syndrome is the most physically disabling of the autism spectrum disorders. Primarily affecting little girls, it usually strikes by 18 months of age, often just after a child has learned to walk and talk. As the cascade of Rett symptoms descend on her, she loses acquired skills, normal movement and speech, and begins the long regression that may leave her in a wheelchair, unable to communicate or use her hands. Extreme anxiety, Parkinson-like tremors, and orthopedic problems are common. Many children have intractable seizures. Some must be fed through tubes. Breathing, cardiac, circulatory and digestive functions are impaired. Many children live to adulthood, requiring total, 24-hour-a-day care.

###

Plastic Surgeons Oppose Proposed Cosmetic Surgery Tax

Plastic Surgeons Oppose Proposed Cosmetic Surgery Tax

Respected physicians across the country, including New Jersey plastic surgeon Robert Zubowski, are making their voices heard in opposition to what would be the first ever tax levied on patients for medical procedures.

Paramus, NJ (PRWEB) December 8, 2009

Last week, democratic leaders in the Senate unveiled their proposal for overhauling the health care system, which included a new 5% tax on elective cosmetic surgery procedures. Senate Democrats argue that the tax, which was a surprise addition to the sweeping 2,074-page bill, will generate $5.8 billion over the next 10 years to be put towards the bill's estimated $849 billion price tag. However, many physicians, including Dr. Robert Zubowski, the American Society of Plastic Surgeons (ASPS) and the American Society of Aesthetic Plastic Surgery (ASAPS) oppose this tax as discriminatory, arbitrary and ineffective.

What's at stake?
This is a discriminatory tax. According to the Aesthetic Society Annual Statistics, 91% of all cosmetic surgery procedures are requested by women.

This will not have considerable consequences on the wealthiest patients but, as usual, affects the middle class. Working women, soccer moms, and scores of others who carefully save and budget to improve their appearance and self esteem with plastic surgery procedures like tummy tuck and breast lift will be penalized for doing so.

Procedures such as breast reduction that have been cited in the literature for improving self esteem and quality of life would be taxed as well.

This provision places plastic surgeons in the role of tax collector and holds physicians liable should an individual fail or refuse to pay the tax. Is that the relationship you want with your medical provider?

"Medical care should not be used as a tool to fix broken finances," said Bergen County, New Jersey plastic surgeon, Dr. Robert Zubowski. "As doctors our first concern always needs to be patient health and safety."

Physicians in New Jersey and across the country are urging cosmetic surgery patients to let their voice be heard by contacting their State Senator at: http://www. senate. gov/general/contact_information/senators_cfm. cfm (http://www. senate. gov/general/contact_information/senators_cfm. cfm)

About Dr. Robert Zubowski, Real Housewives of New Jersey Plastic Surgeon

Dr. Robert Zubowski is a renowned New Jersey plastic surgeon who has been addressing the cosmetic surgery, breast augmentation, and reconstructive needs of women, men and children for more than 20 years. He completed his general surgery residency at New York Medical College and an additional residency at the prestigious Cleveland Clinic Foundation, He has served as an associate professor of Plastic Surgery at New York Medical College and as the plastic surgery specialty director of the Cleveland Clinic Foundation Alumni Association, where he is also an adjunct staff member. He is a former associate director of plastic surgery at Ridgewood's The Valley Hospital and holds a Certificate of Advanced Education in Cosmetic Surgery from the American Board of Plastic Surgery.

Dr. Zubowski is also co-founder of the New Jersey chapter of Image Reborn, a non-profit support group for breast reconstruction patients and he works pro bono for Interplast, traveling to Third World countries to perform reconstructive surgeries for children born with birth defects. He also invests in his own community, formerly serving as president of his town's Board of Health and as a member of its recreation commission.

Dr. Zubowski is a member of the American Society of Plastic Surgeons, the American Society for Plastic Surgery, the American Medical Association, and a Fellow of the American College of Surgeons. He has appeared as an expert on numerous news and talk shows including The View and Fox News, and was recently featured in a segment of The Real Housewives of New Jersey. He was also was voted Bergen County, New Jersey's number one plastic surgeon by the Bergen Record.

For more information about Dr. Zubowski's New Jersey plastic surgery practice, contact Anne Carbone at the Robert Zubowski, M. D. Center for Plastic and Reconstructive Surgery. 201-261-7550.

###

Razorfish Launches Independent Dedicated Health Brand

Razorfish Launches Independent Dedicated Health Brand

Razorfish Health Specializes in Pharma, Health and Wellness.

Philadelphia, PA (PRWEB) March 1, 2010

Acknowledging more than 13 years of experience in the healthcare industry and recognizing a large demand and need for specialization, Razorfish has launched Razorfish Health, a dedicated health and wellness division that will be headquartered in Philadelphia. Katy Thorbahn, who helped build the Philadelphia health practice, will lead the new entity as general manager.

"Razorfish Health is born from the unparalleled technological expertise of Razorfish and the genuine creativity, insight and understanding of the sensitivities of health," said Bob Lord, CEO, Razorfish. "For more than 13 years, Katy's team has been building relationships with health clients and it's now time to take our next step with the launch of this brand."

With digital at its core, and an unrivaled pedigree in technology, Razorfish Health is the go-to partner to create brand experiences that give people the means to make better lifestyle choices now, and in turn, more informed decisions down the road. The agency serves the pharmaceutical, healthcare and wellness industries with a client roster currently including more than 50 brands.

"Healthcare is a different industry than any other, and that's why we're making this dedicated effort. Both the healthcare industry and technology in general are experiencing landmark change, and with that enormous opportunities to create direct connections with patients, caregivers and healthcare professionals," said Thorbahn. "With this launch we are sending a message to our longtime and future clients that we are dedicated to healthcare and all of its intricacies."

Razorfish Health clients put digital at the core of their ability to improve, even transform, their businesses. The company applies offerings that encompass digital advertising, website design, search, email, analytics, and social media, among other capabilities. Razorfish Health also advises marketers on Social Influence Marketing, the company's trademark approach for employing social media and social influencers to achieve the marketing and business needs of an organization.

General Manager Thorbahn will report to David Kramer. As CEO overseeing the Health agencies for Razorfish and Digitas, Kramer will work with the leaders of each agency to continue to build strong autonomous brands.

"David Kramer has unmatched experience in leading a highly specialized digital health agency to global success. When paired with my expertise in managing the health-focused Philadelphia office, we have in place an unbeatable leadership team," said Thorbahn.

Publicis Groupe is a global leader in digital and healthcare communications. The scale of the holding company offers global reach and buying power, as well as access to the network of VivaKi healthcare talent and resources.

About Razorfish Health
Razorfish Health is a key partner for health and wellness companies who want to grow their business by engaging with and improving the lives of their customers. With a focus on creating brand experiences that build our clients' business, we leverage our unique mix of insight, technology, creativity, and industry savvy to transform the health and wellness community so that our clients can build healthy relationships that last. Headquartered in Philadelphia, Razorfish Health is a brand of Razorfish, and a member of the Paris-based Publicis Groupe S. A. (Euronext Paris: FR0000130577), the world's third largest communications group, second largest media counsel and buying group, and a global leader in digital and healthcare communications.

RazorfishHealth. com | twitter. com/RazorfishHealth (http://www. twitter. com/Razorfishhealth) | facebook. com/RazorfishHealth (http://www. facebook. com/razorfishhealth)

About Razorfish
Razorfish creates experiences that build businesses. As one of the largest interactive marketing and technology companies in the world, Razorfish helps its clients build better brands by delivering business results through customer experiences. Razorfish combines the best thought leadership of the consulting world with the leading capabilities of the marketing services industry to support our clients' business needs, such as launching new products, repositioning a brand or participating in the social world. With a demonstrated commitment to innovation, Razorfish continues to cultivate our expertise in Social Influence Marketing, emerging media, creative design, analytics, technology and user experience. Razorfish has offices in markets across the United States, and in Australia, China, France, Germany, Japan, Spain and the United Kingdom. Clients include Carnival Cruise Lines, MillerCoors, Levi Strauss & Co., McDonald's and Starwood Hotels. Razorfish is part of the Publicis Groupe (Euronext Paris: FR0000130577) VivaKi organization. Visit www. razorfish. com for more information. Follow Razorfish on Twitter at @razorfish.

###

Digital Signature Solution by CoSign Desktop Allows All Organization Sizes to Effectively Scale their Signing Solution

Digital Signature Solution by CoSign Desktop Allows All Organization Sizes to Effectively Scale their Signing Solution

CoSign® Desktop, ARX's (Algorithmic Research) digital signature solution designed specifically for departmental deployment within organizations and small office use, is debuting at DEMOfall 08.

San Francisco, CA (PRWEB) September 8, 2008

ARX announces CoSign Desktop, a new addition to the CoSign line of products, which addresses an existing gap in the digital signature market. Previous to the release of CoSign Desktop, digital signature solutions were typically designed for the requirements of medium to large scale deployments, ignoring the needs of organizations with a small number of users. CoSign Desktop, however, allows both individual departments within organizations as well as small office and home office (SoHos) organizations the opportunity to implement a digital signature solution that is scalable, complementing potential future growth.

Like CoSign, CoSign Desktop enables users to quickly and easily add CoSign digital signatures (http://www. arx. com/products/cosign-digital-signatures. php) to documents in all major applications and file formats including: Word, Excel®, Outlook®, PDF®, TIFF, AutoCAD®, InfoPath®, and more. Users can sign and seal documents and forms, comply with regulations calling for the protection of documents, and save on costs associated with paper-handling. By combining the small scale design of CoSign Desktop, with the capacity to scale to the enterprise-focused CoSign digital signature solution, ARX has bridged the gap that prevented an entire business segment from intuitive digital signature solutions.

"It was clear from the feedback we were receiving from vendors and customers that this segment of the market had a specific need that wasn't being met by pre-existing digital signature solutions (http://www. arx. com/documents/10-Tips-for-Selecting-the-Best-Digital-Signature-Solution. php)," said Gadi Aharoni, CEO, ARX. "As the digital signature company, we will continue to expand our product line in order to cater to the needs of the marketplace."

About CoSign Digital Signatures
The CoSign approach means digital signature standards and efficiencies across your operations. Signing and sealing documents with CoSign immediately expedites business processes, reduces costs, increases security and enables organizations to comply with diverse regional and industry regulations. CoSign works with all major applications and document formats including: Microsoft® Word, Excel®, Outlook®, Adobe® PDF, TIFF, AutoCAD®, InfoPath®, Lotus Forms, and many more. CoSign signatures are being used by hundreds of thousands of users in Enterprise, B2B and B2C processes, to learn why please see our white papers and product details at www. arx. com/products/cosign-digital-signatures. php (http://www. arx. com/products/cosign-digital-signatures. php).

About The Digital Signature Company - ARX (Algorithmic Research)
ARX is a global provider of digital signature solutions for life sciences, healthcare, government, engineering, and manufacturing organizations. ARX has over 20 years of experience assisting life sciences, healthcare, governmental, engineering, and manufacturing businesses cost effectively secure, streamline, and scale their business processes and transactions. The company specializes in enabling organizations of any size to scale digital signature and security solutions at the lowest TCO while retaining proper control mechanisms that are required by legislation, regulation and industry best practice.
For more information, please visit http://www. arx. com (http://www. arx. com).

CoSign is a registered trademark and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.

###

Dr. Catrise Austin, "Dentist To The Stars" Celebrates 10th Anniversary of VIP Smiles at the World Famous Apollo Theater December 17, 2008

Dr. Catrise Austin, "Dentist To The Stars" Celebrates 10th Anniversary of VIP Smiles at the World Famous Apollo Theater December 17, 2008

Dr. Catrise L. Austin, celebrity "Dentist to the Stars", will host a star studded 10th Anniversary celebration of VIP Smiles, New York City's top cosmetic dental practice, at the World Famous Apollo Theater. This momentous occasion will take place Wednesday, December 17, 2008 from 6PM - 11PM. The event marks a milestone in an illustrious career for the young trailblazing dental expert, spokesperson, speaker, and author.

New York, New York (PRWEB) December 17, 2008

Dr. Catrise L. Austin, celebrity "Dentist to the Stars", will host a star studded 10th Anniversary celebration of VIP Smiles, New York City's top cosmetic dental practices, at the World Famous Apollo Theater. This momentous occasion will take place Wednesday, December 17, 2008 from 6PM - 11PM. The event marks a milestone in an illustrious career for the young trailblazing dental expert, spokesperson, speaker, and author.

Always fiercely independent and goal oriented, Dr. Austin a Flint Michigan native founded VIP Smiles in 1998 just 2 years after graduating from the famed University of Maryland Dental School-the first dental school in the world. Dr. Austin's vision has always been to empower people to improve their dental health and to have a beautiful, confident smile. "Improving my smile when I was 15 changed my life!" says Austin. "I no longer had to hide behind my smile which helped me feel like a new person."

Her celebrity clientele includes but is not limited to Paula Abdul, Toni Braxton, the late Isaac Hayes, Actors Rexx Lee and Kevin Sorbo, rapper/actor Common, Omarosa, model Eva Pigford, and American Gladiator Mike "Titan" O'Hearn.

Dr. Austin has been profiled in Glamour, Essence, Self and Black Enterprise as well as Good Morning America, Discovery Health, and local news shows. In addition, she is a regular on the speakers' circuit. In 2009, Morgan James Publishing will be releasing her self-help consumer dental book titled "5-Steps to an A-list Smile".

When asked why the Apollo Theater for her anniversary celebration, Dr. Austin states, "As the dentist to the stars, I wanted to celebrate in a historic location where stars are made and legends are born. When the history books are written, I hope that my work in the community and in my practice will be considered legendary!"

For information, interviews and press passes, contact, Raymond Lewis, 212-427-3167, 310-890-7300.

###